Zobrazeno 1 - 10
of 304
pro vyhledávání: '"EANM"'
Autor:
David Groheux, Sofia C. Vaz, Philip Poortmans, Ritse M. Mann, Gary A. Ulaner, Gary J.R. Cook, Elif Hindié, John Patrick Pilkington Woll, Heather Jacene, Isabel T. Rubio, Marie-Jeanne Vrancken Peeters, Elizabeth H. Dibble, Lioe-Fee de Geus-Oei, Stephanie L. Graff, Fatima Cardoso
Publikováno v:
Breast, Vol 78, Iss , Pp 103806- (2024)
Purpose: The recently released EANM/SNMMI guideline, endorsed by several important clinical and imaging societies in the field of breast cancer (BC) care (ACR, ESSO, ESTRO, EUSOBI/ESR, EUSOMA), emphasized the role of [18F]FDG PET/CT in management of
Externí odkaz:
https://doaj.org/article/44ebf936197f4ec5a652aa9113097367
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elisa Jiménez-Ortega, Raquel Agüera, Ana Ureba, Marcin Balcerzyk, Amadeo Wals-Zurita, Francisco Javier García-Gómez, Antonio Leal
Publikováno v:
Tomography, Vol 8, Iss 2, Pp 1097-1112 (2022)
The purpose of this work is to present useful recommendations for the use of [18F]FDG-PET/CT imaging in radiotherapy planning and monitoring under different versions of EARL accreditation for harmonization of PET devices. A proof-of-concept experimen
Externí odkaz:
https://doaj.org/article/1f637bddd55b46b1a487144bf914f397
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Molecules, Vol 27, Iss 13, p 3997 (2022)
Technetium-99m macroaggregated albumin ([99mTc]Tc-MAA) is an injectable radiopharmaceutical used in nuclear medicine for lung perfusion scintigraphy. After changing to a new batch of macroaggregated albumin (MAA), we saw unwanted uptake in the liver
Externí odkaz:
https://doaj.org/article/7849035b903743d296225d99e4cc4f61
Autor:
Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber, Michael S. Hofman, Louise Emmett, Jeremie Calais, Joseph R. Osborne, Amir Iravani, Phillip Koo, Liza Lindenberg, Richard P. Baum, Murat Fani Bozkurt, Roberto C. Delgado Bolton, Samer Ezziddin, Flavio Forrer, Rodney J. Hicks, Thomas A. Hope, Levent Kabasakal, Mark Konijnenberg, Klaus Kopka, Michael Lassmann, Felix M. Mottaghy, Wim J. G. Oyen, Kambiz Rahbar, Heiko Schoder, Irene Virgolini, Lisa Bodei, Stefano Fanti, Uwe Haberkorn, Ken Hermann
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2830-2845
European journal of nuclear medicine and molecular imaging, vol 50, iss 9
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2830-2845
European journal of nuclear medicine and molecular imaging, vol 50, iss 9
Prostate-specific membrane antigen (PSMA) is expressed by the majority of clinically significant prostate adenocarcinomas, and patients with target-positive disease can easily be identified by PSMA PET imaging. Promising results with PSMA-targeted ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2bbc72da30d073fb429dcfb7f81700
https://doi.org/10.1007/s00259-023-06255-8
https://doi.org/10.1007/s00259-023-06255-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 50, 61-66. SPRINGER
Artificial intelligence (AI) is coming into the field of nuclear medicine, and it is likely here to stay. As a society, EANM can and must play a central role in the use of AI in nuclear medicine. In this position paper, the EANM explains the precondi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf5f4383f5b566d7059fb12f0366cf5
https://research.rug.nl/en/publications/87a8e1f4-52e6-4277-9038-f188832cb969
https://research.rug.nl/en/publications/87a8e1f4-52e6-4277-9038-f188832cb969
Autor:
Sofia C. Vaz, Judit A. Adam, Roberto C. Delgado Bolton, Pierre Vera, Wouter van Elmpt, Ken Herrmann, Rodney J. Hicks, Yolande Lievens, Andrea Santos, Heiko Schöder, Bernard Dubray, Dimitris Visvikis, Esther G. C. Troost, Lioe-Fee de Geus-Oei
Publikováno v:
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
European journal of nuclear medicine and molecular imaging, 49(4), 1386-1406. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging 49(2022), 1386-1406
Vaz, S C, Adam, J A, Delgado Bolton, R C, Vera, P, van Elmpt, W, Herrmann, K, Hicks, R J, Lievens, Y, Santos, A, Schöder, H, Dubray, B, Visvikis, D, Troost, E G C & de Geus-Oei, L-F 2022, ' Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 4, pp. 1386-1406 . https://doi.org/10.1007/s00259-021-05624-5
European Journal of Nuclear Medicine and Molecular Imaging, 49, 1386-1406. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49(4), 1386-1406. Springer, Cham
European Journal of Nuclear Medicine and Molecular Imaging, 49(4), 1386-1406. Springer Verlag
European journal of nuclear medicine and molecular imaging, 49(4), 1386-1406. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging 49(2022), 1386-1406
Vaz, S C, Adam, J A, Delgado Bolton, R C, Vera, P, van Elmpt, W, Herrmann, K, Hicks, R J, Lievens, Y, Santos, A, Schöder, H, Dubray, B, Visvikis, D, Troost, E G C & de Geus-Oei, L-F 2022, ' Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 4, pp. 1386-1406 . https://doi.org/10.1007/s00259-021-05624-5
European Journal of Nuclear Medicine and Molecular Imaging, 49, 1386-1406. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 49(4), 1386-1406. Springer, Cham
European Journal of Nuclear Medicine and Molecular Imaging, 49(4), 1386-1406. Springer Verlag
Purpose 2-[18F]FDG PET/CT is of utmost importance for radiation treatment (RT) planning and response monitoring in lung cancer patients, in both non-small and small cell lung cancer (NSCLC and SCLC). This topic has been addressed in guidelines compos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b84e85e4cf6e42e0bae269d929da3db
https://doi.org/10.1007/s00259-021-05624-5
https://doi.org/10.1007/s00259-021-05624-5